SMARTCONTROL TECHNOLOGY Trademark

Trademark Overview


On Tuesday, May 24, 2022, a trademark application was filed for SMARTCONTROL TECHNOLOGY with the United States Patent and Trademark Office. The USPTO has given the SMARTCONTROL TECHNOLOGY trademark a serial number of 97425421. The federal status of this trademark filing is REGISTERED as of Tuesday, August 15, 2023. This trademark is owned by GlaxoSmithKline Consumer Healthcare, L.P.. The SMARTCONTROL TECHNOLOGY trademark is filed in the Pharmaceutical Products category with the following description:

Rate controlling membrane sold as a unit with nicotine patches for smoking cessation
smartcontrol technology

General Information


Serial Number97425421
Word MarkSMARTCONTROL TECHNOLOGY
Filing DateTuesday, May 24, 2022
Status700 - REGISTERED
Status DateTuesday, August 15, 2023
Registration Number7136511
Registration DateTuesday, August 15, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 30, 2023

Trademark Statements


Goods and ServicesRate controlling membrane sold as a unit with nicotine patches for smoking cessation
Disclaimer with Predetermined Text"TECHNOLOGY"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 31, 2022
Primary Code005
First Use Anywhere DateSaturday, September 30, 2006
First Use In Commerce DateSaturday, September 30, 2006

Trademark Owner History


Party NameHALEON US LP
Party Type31 - New Owner After Registration
Legal Entity Type13 - Limited Partnership
AddressWARREN, NJ 07059

Party NameGlaxoSmithKline Consumer Healthcare, L.P.
Party Type30 - Original Registrant
Legal Entity Type13 - Limited Partnership
AddressWilmington, DE 19808

Party NameGlaxoSmithKline Consumer Healthcare, L.P.
Party Type20 - Owner at Publication
Legal Entity Type13 - Limited Partnership
AddressWilmington, DE 19808

Party NameGlaxoSmithKline Consumer Healthcare, L.P.
Party Type10 - Original Applicant
Legal Entity Type13 - Limited Partnership
AddressWilmington, DE 19808

Trademark Events


Event DateEvent Description
Wednesday, February 21, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, August 15, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 15, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, May 30, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 30, 2023PUBLISHED FOR OPPOSITION
Wednesday, May 10, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, April 27, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 21, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 21, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 21, 2023ASSIGNED TO LIE
Thursday, January 5, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, October 12, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, October 12, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 12, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, October 12, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, October 12, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 12, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, October 3, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, October 3, 2022FINAL REFUSAL E-MAILED
Monday, October 3, 2022FINAL REFUSAL WRITTEN
Thursday, August 25, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 25, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 25, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 28, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 28, 2022NON-FINAL ACTION E-MAILED
Thursday, July 28, 2022NON-FINAL ACTION WRITTEN
Thursday, July 21, 2022ASSIGNED TO EXAMINER
Tuesday, May 31, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 27, 2022NEW APPLICATION ENTERED